CVE-2026-50034

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information

State: Published
Severity: 7.1 High
Published: Jun 18, 2026
Updated: Jun 22, 2026
Reserved: Jun 10, 2026

Description

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

Scores

CVSS	Score	Vector	Source
4.0	7.1 High	CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N	icscert
3.1	6.5 Medium	CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N	icscert

Weaknesses

CWE-319

Affected Products

Product	Versions
Blood Glucose Monitoring System (Model No. APG-01 BT)Apollo Pharmacy	0x0110_v1.1.0Affected

References

https://www.apollopharmacy.in/contact-us
https://www.cisa.gov/news-events/news/understanding-bluetooth-technology
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01
https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json

Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.